About Cannapharmarx, inc.

About company

CannaPharmaRx operates within the healthcare community as a leader in the Endocannabinoid System (ECS) research and development. The marketplace for cannabis-based products is rapidly undergoing metamorphosis. From its longstanding position as a $30-50 billion dollar illegal U.S. industry at the federal and state levels, it is now a state-regulated (still federally illegal) $2.53 billion industry. Projected sales growth is 700% over the next five years, making it the fastest-growing industry in the US. More than 20 states have adopted medical or adult-use legislation, with 14 more states expected to follow suit in the next 18 months.